FDA stresses birth defect risks with Roche drug
May 16th, 2008 in Medicine & Health / Medications(AP) -- Health regulators warned again Friday that Roche and Novartis drugs prescribed to organ transplant patients can cause miscarriages and birth defects when used by pregnant women.
Content from The Associated Press expires 15 days after original publication date. For more information about The Associated Press, please visit www.ap.org .